Daily online treatment evaluation is essential for proton therapy, which is sensitive to daily anatomy and setup uncertainties. We have developed a program based on a commercial treatment planning system (TPS) to streamline the online evaluation process using pre-treatment cone-beam CT (CBCT) images. Herein, we evaluate the speed and accuracy of the tool based on clinical proton plans.Data from 25 previously treated proton patients (7 HN, 11 lung, and 7 prostate) at our institution were evaluated. Corrected CBCT (cCBCT) images were generated using a research version of the TPS, which removes artifacts and calibrates HU for proton dose calculation. A quality assurance simulation CT (QACT) scanned on the same day as the CBCT is deformed to the cCBCT and used as a reference (dQACT). The cCBCT is deformed to the treatment planning CT (TPCT), and all contours on the initial TPCT were deformed to the cCBCT and then rigidly copied to the dQACT. Original clinical treatment plans were applied to both the cCBCT and dQACT, and the doses were calculated with the GPU-based Monte-Carlo dose calculation engine at 0.5% statistical uncertainty. The entire evaluation time (Eval_time) from importing CBCT image to completing final dose calculation for cCBCT was recorded. Plan parameters, including the number of beams (N_bm), proton spot number (N_sp), dose grid voxel numbers (N_voxel), were collected. Pearson correlation coefficient between the Eval_time and the N_bm, N_sp, and N_vosel were calculated. Dosimetric parameters were calculated for the cCBCT and compared to those calculated from the reference dQACT. Dosimetric parameters of interest included the following: for all, CTV D99, D95, and V100, and plan maximum dose (Dmax); for H&N cases, parotid mean dose (P_Dmean) and V30Gy (P_V30), and oral cavity mean dose (C_Dmean); and for H&N and lung cases, spinal cord max dose (SC_Dmax).Mean online Eval_time is 106.6 ± 24.9s for all patients, with HN as the fastest site 87.9 ± 17.5s for HN, 104.5 ± 15.9s for lung, 128.5 ± 28.0s for prostate, P < 0.01. The corresponding (N_bm, N_sp, N_voxel) were (3.9, 7781, 2.6E6) for HN, (3.3, 11080, 2.4E6) for lung, and (3.0, 10484, 3.8E6) for prostate. Eval_time was significantly correlated to N_sp (P = 0.02), but not to N_bm and N_voxel. The absolute differences for CTV D99, D95, V100, plan Dmax, HN P_Dmean, P_V30, C_Dmean, and SC_Dmax are 0.85 ± 0.60%, 0.39 ± 0.22%, 0.48 ± 0.41%, 0.46 ± 0.48%, 0.08 ± 0.05Gy, 0.05 ± 0.06%, 0.21 ± 0.20 Gy, and 0.57 ± 0.53Gy, respectively.Online evaluation can be achieved within 2 minutes for most clinical proton cases (80% in this study) with the commercial TPS. The speed can be further increased with reduced OAR mapping, fine-tuned deformable registration, optimized and reduced spot number in the initial plans, and upgraded computer server. This proposed method may optimize the efficiency and quality of care for proton radiotherapy.
Read full abstract